| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |